Asbestos (Exposure Dangers, Testing, Symptoms)

Title: Asbestos (Exposure Dangers, Testing, Symptoms)Category: Diseases and ConditionsCreated: 2/21/2000 12:00:00 AMLast Editorial Review: 2/12/2018 12:00:00 AM
Source: MedicineNet Lungs General - Category: Respiratory Medicine Source Type: news

Related Links:

NEW YORK (Reuters) - A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson&Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
A California jury on Thursday ordered Johnson&Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to asbestos in the company's baby powder, pushing the total damages award in the case to $25.7 million.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
A California jury has ordered Johnson and Johnson to pay another $4 million to an Oregon mother-of-two who says that asbestos in the company's baby powder gave her mesothelioma.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Conditions:   Cervical Cancer;   Microsatellite Instability (MSI)-High Endometrial Cancer;   Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]);   Esophageal Cancer;   Hepatocellular Carcinoma;   Melanoma (Uveal Melanoma Excluded);   Merkel Cell Carcinoma;   Mesothelioma;   MSI-high Colorectal Cancer;   Non-small Cell Lung Cancer (NSCLC);   Ovarian Cancer;   Squamous Cell Carcinoma of the Head and Neck (SCCHN);   Small Cell Lung Cancer (SCLC); &n...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
A California jury has ordered Johnson and Johnson to pay another $4 million to an Oregon mother-of-two who says that asbestos in the company's baby powder gave her mesothelioma.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
American Journal of Industrial Medicine, EarlyView.
Source: American Journal of Industrial Medicine - Category: Occupational Health Authors: Source Type: research
A California jury hit Johnson&Johnson and other companies with a $25.75 million verdict, saying the company was negligent and did not warn consumers about possible health risks from its Baby Powder.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
(Reuters) - A California jury on Thursday ordered Johnson&Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to asbestos in the company's baby powder, pushing the total damages award in the case to $25.7 million.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Johnson &Johnson suffered its second trial loss in two months Wednesday linking the company’s baby powder to deadly asbestos-related cancer. A Los Angeles jury awarded $21.7 million in compensatory damages to Joanne Anderson, who said she developed mesothelioma after being exposed to asbestos in J&J baby powder laced with the carcinogen. J&J was ordered to pay an additional $4 million in punitive damages Thursday, bringing the total award for Anderson to $25.7 million. The verdict comes less than two months after Johnson &Johnson’s first loss in an asbestos-related talcum powder lawsuit. In April, a N...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Oncologists in 2019 may begin offering patients with pleural mesothelioma a novel, tumor-fighting tool involving electric currents that enhance standard-of-care treatment and extend survival, according to the device manufacturer. Tumor Treating Fields (TTF) is the name of the new technology. It is designed to disrupt cancer cell division through electric fields tuned to specific frequencies. In an ongoing multicenter phase II clinical trial in Europe, TTF has shown an ability in first-line treatment to improve the effectiveness of standard chemotherapy for mesothelioma patients. The trial success has led the manufacturer t...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
More News: Asbestosis | Respiratory Medicine